Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TissueGene-C in Grade 3 Knee Osteoarthritis
NCT01221441Phase 2Completed
- Sponsor
- Kolon TissueGene, Inc.
- Start
- May 2011
- Primary completion
- Oct 2013
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Invossa in osteoarthritis (OA), sponsored by Kolon TissueGene, Inc.. Started May 2011; status: completed.
02
Drugs
Invossa
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01221441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221441.